S5 Ep18: How an MLM Urged One Survivor to Use Her Cancer Diagnosis to Push Products
Cancer Horizons9 Maalis 2023

S5 Ep18: How an MLM Urged One Survivor to Use Her Cancer Diagnosis to Push Products

At the time of her cervical cancer diagnosis in 2015, Emily Lynn Paulson was involved in a multi-level marketing (MLM) company — a business where individuals sign up to sell products, and then are encouraged to recruit others to distribute under them.


“When I got the diagnosis, I thought ‘OK, I’m going to have to step back and take a break from this,” Paulson said in an interview with CURE®. “I was really encouraged by the people in my upline (saying), ‘Use this to your advantage. You’re going through this thing. People love personal stories, people love vulnerability.’”


After Paulson was diagnosed, others in the company encouraged her to use her diagnosis to sell more products; she said that this type of emotional manipulation was not an uncommon tactic to make more money.


READ MORE: The Dark Side of Cancer and Social Media


Meanwhile, Paulson underwent a trachelectomy (cervix removal) and was working on getting sober after her bout with cancer. Two years later, she received a second diagnosis, which led to a hysterectomy, and more doubt about the company she was working for. Eventually, when the COVID-19 pandemic hit, she said she realized how predatory these sales tactics were and left the company to become a sobriety coach and author of the book, “Hey Hun: Sales, Sisterhood, Supremacy, and the Other Lies Behind Multilevel Marketing.”


“Being in an MLM, you really target people’s pain points… there’s a solution to every pain point; it’s just a very predatory design,” she said.


In this episode of the “Cancer Horizons” podcast, Paulson discusses her cancer experience, life in the MLM, sobriety and more.


For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.


Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(295)

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

CURE sat down with Dr. Natalie S. Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with metastatic triple-negative breast cancer. Berg...

31 Joulu 202514min

S7 Ep1: The Importance of Spotting Endometrial Cancer

S7 Ep1: The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

18 Maalis 202510min

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

17 Syys 202419min

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma. And finally, we’ll discuss another ca...

4 Maalis 20247min

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, an...

4 Maalis 202410min

S6 Ep20: FDA Approvals from February 2024

S6 Ep20: FDA Approvals from February 2024

Last week, the Food and Drug Administration (FDA) approved four different therapies in the oncology space — one of which, Amtagvi, marks the first cellular therapy for the treatment of solid cancers. ...

23 Helmi 20246min

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

Last week, we saw some FDA approvals for a new drug regimens, as well as some expert opinion about cancer vaccines. Additionally research touched upon the potential benefit of concurrent ctDNA and tum...

19 Helmi 20249min

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews. Also last week, we covered researc...

12 Helmi 20247min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-hereilla
rss-duodecim-lehti
rss-poliisin-mieli
tiedekulma-podcast
rss-ilmasto-kriisissa
docemilia
hippokrateen-vastaanotolla
sotataidon-ytimessa
filocast-filosofian-perusteet
rss-radplus
rss-tiedetta-vai-tarinaa
rss-opeklubi
rss-kasvikutsut
rss-totuuden-liepeilla